| Patents for C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576) |
|---|
| 07/09/2009 | US20090176752 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 07/09/2009 | CA2710934A1 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof and medicinal products containing the derivative |
| 07/08/2009 | EP1622926B1 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 07/08/2009 | CN101475623A Steroid compounds with endothelin receptor A antagonistic activity and intermediate thereof |
| 06/24/2009 | CN101466723A Industrial process for the synthesis of 17a-acetoxy-11ss-[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 06/23/2009 | US7550450 Prostate cancer treatment |
| 05/07/2009 | WO2009004394A3 PROCESS FOR THE SYNTHESIS OF 9α-HYDROXY-STEROIDS |
| 05/05/2009 | US7528123 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 04/22/2009 | CN100480256C Method for synthesizing Drospirenone |
| 04/09/2009 | WO2008155534A3 Neurosteroid compounds |
| 04/07/2009 | US7514420 Steroids having 1,8-unsaturation and formulations comprising same |
| 04/01/2009 | CN100473660C Process for preparing eplerenone |
| 03/19/2009 | WO2009001148A3 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11β-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS |
| 02/26/2009 | US20090053294 Anti Mineralocorticoid Therapy of Infection |
| 02/25/2009 | EP2027140A1 Industrial process for the synthesis of 17 alpha -acetoxy-11 beta -[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 01/29/2009 | US20090029953 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter |
| 01/28/2009 | CN101353369A Preparation of 17 beta-spiro-1í»,2í»-epoxyethane steride compound |
| 01/22/2009 | US20090023695 METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE |
| 01/08/2009 | CA2689422A1 Process for the synthesis of 9.alpha.-hydroxy-steroids |
| 01/07/2009 | EP2010555A2 Method for preparing 4-[17beta -methoxy-17 -alpha methoxymethyl-3-oxoestra-4,9-dien-11beta -yl]benzaldehyde (e)-oxime (asoprisnil) |
| 12/31/2008 | CA2677195A1 Industrial method for the synthesis of 17-acetoxy-11.beta.-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
| 12/24/2008 | CA2691071A1 Neurosteroid compounds |
| 12/10/2008 | CN101318986A Method for synthesizing eplerenone |
| 12/10/2008 | CN101318983A Whorl[(5 beta, 6 beta, 15 beta, 16 beta-dimethylene-androstane-14 beta-hydrogen-5, 7-diene-3-ketone)-17 alpha-2'-(1'-oxygen-cyclopentane-5'-ketone)] and synthesis process |
| 12/09/2008 | US7462610 Prostate cancer treatment |
| 11/06/2008 | WO2008067086A3 Compositions and methods for suppressing endometrial proliferation |
| 09/25/2008 | US20080234478 Purification; epoxidationof trienone, precipitation, crystallization |
| 09/24/2008 | CN100420380C Use of sapogenin compound as bactericidal agent |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |
| 08/26/2008 | US7417140 17 beta -Hydroxy-7 alpha -(2'-hydroperoxy-2'-methoxyacetyl)pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone chemical intermediate useful to prepare eplerenone a hypotensive agent, useful for treating congestive heart failure |
| 08/26/2008 | CA2394731C Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 08/26/2008 | CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 08/21/2008 | US20080200668 Industrial Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene-3-Oxo-17Alpha-Pregn-4-Ene-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process |
| 08/19/2008 | US7414127 7 α-Enedione-substituted steroid compounds |
| 08/14/2008 | US20080194812 Making drospirenone; chemical intermediates e.g. carbethoxy-drospirenone; industrial scale, safe (no chromium catalyst), meets purity requirements |
| 08/13/2008 | EP1339733B1 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 08/12/2008 | US7411062 17-Beta -hydroxy-7-alpha-(2'-oxoacetyl or alkanoylcarbonyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone; intermediate for preparing eplerenone |
| 08/05/2008 | CA2272721C Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin d analogs, and other compounds |
| 07/15/2008 | CA2208605C 14.alpha.,17.alpha.-c2-bridged 19-nor-progesterone derivatives |
| 07/10/2008 | US20080167254 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/05/2008 | CA2673128A1 Compositions and methods for suppressing endometrial proliferation |
| 06/03/2008 | US7381718 new process for the preparation of a key intermediate |
| 05/22/2008 | WO2008058767A1 Progesterone receptor antagonists |
| 05/22/2008 | CA2669767A1 Progesterone receptor antagonists |
| 05/14/2008 | CN101177446A Novel method for stereo-selective chemosynthesis of drospirenone |
| 04/30/2008 | CN100384866C Process for prepn. of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for epoxidation of olifinic double bonds |
| 04/24/2008 | WO2007118717A3 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 04/17/2008 | WO2008011005A3 Antiangiogenic agents |
| 04/17/2008 | US20080090792 Selective glucocorticoid receptor agonists |
| 04/15/2008 | CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 04/09/2008 | CN100379753C Intermediates for 16 beta -methyl steroids |
| 03/25/2008 | US7348320 lower toxicity and higher selectivity |
| 03/20/2008 | US20080070881 Prostate Cancer Treatment |
| 03/20/2008 | US20080069886 Spironolactone nanoparticles, compositions and methods related thereto |
| 03/19/2008 | CN101143149A Compound extracting and separating method and its application as medicine |
| 02/20/2008 | CN100369927C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 02/13/2008 | CN100368427C Method for production of 4-(17 alpha-substituted-3-oxoestra-4,9-dien-11-yl) benzaldehyd-(1E or 12)-oximes |
| 02/13/2008 | CN100368425C 6,7-oxygenated steroids and uses related thereto |
| 02/06/2008 | CN101117350A Method for preparing steroids and novel intermediate compound used therein |
| 01/31/2008 | US20080027237 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/24/2008 | WO2008011005A2 Antiangiogenic agents |
| 01/10/2008 | US20080009472 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/03/2008 | US20080004250 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/03/2008 | DE102006030416A1 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate 18-methyl-19-nor-androst-4-ene-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one), as well as pharmaceutical compositions containing them |
| 01/02/2008 | CN100358913C C22 steroid compounds and their synthesizing method |
| 12/26/2007 | CN101092443A Method for synthesizing Drospirenone |
| 12/26/2007 | CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 12/21/2007 | WO2007144674A1 INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17α-ACETOXY-11β-[4-(N,N-DIMETHYL-AMINO)- PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS |
| 12/21/2007 | CA2653552A1 Industrial process for the synthesis of 17.alpha.-acetoxy-11.beta.-[4-(n,n-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 12/20/2007 | US20070292967 Assay for Ligands of the Ecdysone Receptor |
| 12/12/2007 | CN100354300C Method of obtaining 17alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione |
| 10/31/2007 | EP1539795B1 Crystalline 17beta-hydroxy-7alpha-(5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone |
| 10/25/2007 | WO2007118717A2 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 09/26/2007 | EP1837343A1 Process for producing (5 alpha, 7 alpha)-3-spiro-2'-(1',3'-dioxolan)-24-oxocholest-22-en-7-yl benzoate |
| 09/11/2007 | US7268241 Therapy for hormone sensitive diseases; contraceptives |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 07/26/2007 | WO2007025780A3 Aldosterone receptor antagonists |
| 07/25/2007 | EP1809649A1 Process for the preparation of 21-hydroxy steroids with control of the epimeric distribution at the c-21 position |
| 07/25/2007 | CN101003560A Midbody of steroid, and application |
| 06/26/2007 | US7235655 Processes to prepare eplerenone |
| 06/20/2007 | EP0973791B1 Process for the preparation of an epoxy compound |
| 06/13/2007 | EP1794177A2 Process for preparing 7 -alkoxycarbonyl substituted steroids |
| 06/13/2007 | CN1321128C Preparation method of 9 alpha, 11 alpha-epoxy-17 beta-hydroxy-3-oxy-17 alpha pregn-4-olefine-7 alpha, 21-diformic acid gammalactone 7-methyl ester |
| 06/07/2007 | US20070129332 Processes to prepare eplerenone |
| 05/31/2007 | US20070123704 7alpha-biscarbonyl-substituted steroid compounds |
| 05/24/2007 | US20070117780 Process to Prepare Eplerenone |
| 05/23/2007 | EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | CA2347345C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds |
| 05/10/2007 | US20070106072 7a-Furyl or thienyl-substituted steroid compounds |
| 05/08/2007 | US7214808 Reacting 3,3-dimethoxy-5alpha, 10alpha-epoxy-estr-9(11)-en-17-one with an active methylene reagent in an inert solvent into an intermediate, regio or stereoselective cleavage of 17-spiroepoxy group |
| 05/03/2007 | US20070100140 used to prepare eplerenone; intermediates |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2073855C Glycoalkaloids for controlling cellular autophagy |
| 03/27/2007 | US7196208 Chemical intermediate; carbonylation using carbon monoxide using palladium catalyst |
| 03/27/2007 | US7196191 Oxidation at a tertiary C H bond to form an alcohol; ketones are formed by oxidizing a secondary C H bond and ring- cleaved diones are formed by oxidizing cis tertiary CH bonds; with a chromium (VI) oxidant and a co-oxidant |
| 03/27/2007 | US7196074 Hormone replacement therapy |
| 03/22/2007 | US20070066579 5-androsten-3beta-ol steroid intermediates and processs for their preparation |